Nostos Genomics

Founded in 2018 and headquartered in Berlin, Nostos Genomics was created from a vision to enhance the speed and accuracy of genetic disease diagnosis. What started as a small initiative has transformed into an innovative enterprise that leverages cutting-edge artificial intelligence through its platform, AION. The name 'Nostos,' derived from the Greek word for 'return home,' encapsulates the mission of helping patients find answers and navigate the often-turbulent waters of genetic conditions.

At the core of Nostos Genomics lies the AION platform, which empowers genetic testing labs worldwide to interpret genomic data with unprecedented speed and precision. Traditional methods of variant interpretation can take weeks and often yield inconclusive results, leaving approximately 70% of individuals without a clear diagnosis after extensive testing. AION revolutionizes this process, producing results in less than two minutes, thus significantly shortening the diagnostic odyssey for patients. Nostos Genomics collaborates with leading genetic testing laboratories to provide actionable insights, ensuring that patients receive timely and accurate diagnoses.